INMED PHARMACEUTICALS INC has a total of 29 patent applications. It increased the IP activity by 171.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are CELTIC PHARMA PEG LTD, QOL MEDICAL LLC and BONTAC BIO-ENGINEERING (SHENZHEN) CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | China | 3 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Micro-structure and nano-technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Fermentation | |
#4 | Enzymes | |
#5 | Microorganisms | |
#6 | Nanostructure applications | |
#7 | Heterocyclic compounds | |
#8 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Hossain Sazzad | 25 |
#2 | Yadav Vikramaditya G | 9 |
#3 | Hallam Steven J | 8 |
#4 | Srivastava Sarvesh K | 8 |
#5 | Roy Protiva R | 8 |
#6 | Ayakar Sonal R | 8 |
#7 | Pawar Sandip V | 8 |
#8 | Kabiri Maryam | 7 |
#9 | Yadav Vikramaditya Ganapati | 6 |
#10 | Mancini Alexandra | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020215164A1 | Compositions and methods for use of cannabinoids for neuroprotection | |
WO2020176998A1 | Compositions and methods for biosynthesis of terpenoids or cannabinoids in a heterologous system | |
WO2019056123A1 | Topical formulations of cannabinoids and use thereof in the treatment of pain | |
AU2018329232A1 | Metabolic engineering of E. coli for the biosynthesis of cannabinoid products | |
KR20200019864A | Ocular Drug Delivery Formulations | |
CN109689045A | Purposes of the topical formulations of cannboid in treatment epidermolysis bollosa and Related connective tissue illness |